Asia Pacific Pain Management Devices Market By Product (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices) By Application (Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications) By Country, Industry Analysis and Forecast, 2020 - 2026
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Asia Pacific Pain Management Devices Market
The Asia Pacific Pain Management Devices Market would witness market growth of 10% CAGR during the forecast period (2020-2026). A number of factors, such as the need for long-term pain management in the geriatric population, the large population base of patients, the negative effects of pain medicines, the development of new pain management technologies, identified reimbursement scenario for spinal cord stimulation (SCS) technologies in developing countries and the widely validated effectiveness of pain management devices for chronic pain treatment. On the other hand, factors such as low knowledge about the availability and usage of pain management devices, a shortage of pain specialists, a limited number of pain clinics in many countries, the presence of a disparity in the prevalence and treatment of chronic pain, and high clinical and purchasing costs of pain management devices hinder the market growth.
The Asia-Pacific region has become an enticing destination for companies engaged in pain relief system manufacturing. The high growth opportunities in this regional segment can be attributed to a variety of factors, including the growing prevalence of chronic diseases, improving the region's healthcare infrastructure, rising middle-class population and disposable income rates, and increasing knowledge of the protection and efficacy of pain management tools.
Based on Product, the market is segmented into Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices. Based on Application, the market is segmented into Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, Kimberly-Clark Corporation, Stryker Corporation, and Colfax Corporation (DJO Global, Inc.)
Scope of the Asia Pacific Pain Management Devices Market Analysis
- Neuromodulation & Neurostimulation Devices
- Analgesic Infusion Pumps and
- Ablation Devices
- Neuropathic Pain
- Musculoskeletal Pain
- Cancer Pain
- Facial & Migraine Pain and
- Other Applications
- South Korea
- Rest of Asia Pacific
- Abbott Laboratories
- Braun Melsungen AG
- Baxter International, Inc.
- Pfizer, Inc.
- Boston Scientific Corporation
- Johnson and Johnson
- Medtronic PLC
- Kimberly-Clark Corporation
- Stryker Corporation
- Colfax Corporation (DJO Global, Inc.)
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free